BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23268645)

  • 1. Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.
    Clay AT; Sharom FJ
    Biochemistry; 2013 Jan; 52(2):343-54. PubMed ID: 23268645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of ATP-dependent multidrug transport by P-glycoprotein.
    Shapiro AB; Ling V
    Acta Physiol Scand Suppl; 1998 Aug; 643():227-34. PubMed ID: 9789565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.
    Lu P; Liu R; Sharom FJ
    Eur J Biochem; 2001 Mar; 268(6):1687-97. PubMed ID: 11248688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
    Romsicki Y; Sharom FJ
    Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the P-Glycoprotein Multidrug Transporter with Sterols.
    Clay AT; Lu P; Sharom FJ
    Biochemistry; 2015 Nov; 54(43):6586-97. PubMed ID: 26484739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
    Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
    J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.
    Shapiro AB; Corder AB; Ling V
    Eur J Biochem; 1997 Nov; 250(1):115-21. PubMed ID: 9431998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study.
    Romsicki Y; Sharom FJ
    Biochemistry; 1997 Aug; 36(32):9807-15. PubMed ID: 9245413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site.
    Lugo MR; Sharom FJ
    Biochemistry; 2005 Jan; 44(2):643-55. PubMed ID: 15641790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
    Al-Shawi MK; Polar MK; Omote H; Figler RA
    J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.
    Lugo MR; Sharom FJ
    Biochemistry; 2005 Oct; 44(42):14020-9. PubMed ID: 16229491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein.
    Shapiro AB; Ling V
    Eur J Biochem; 1998 May; 254(1):181-8. PubMed ID: 9652412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function.
    Sharom FJ
    Front Oncol; 2014; 4():41. PubMed ID: 24624364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.
    Qu Q; Sharom FJ
    Biochemistry; 2002 Apr; 41(14):4744-52. PubMed ID: 11926837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
    Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
    Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
    PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors.
    Eckford PD; Sharom FJ
    Biochem Cell Biol; 2006 Dec; 84(6):1022-33. PubMed ID: 17215888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
    Essodaigui M; Broxterman HJ; Garnier-Suillerot A
    Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.